netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:

 

1. Wherever possible antibiotics should be prescribed orally

2. Antibiotics should be:

  • Administered only for as long as necessary to treat the infection
  • Changed from IV to oral as soon as possible

3. Sugar free liquids are preferred where available, and SF identifies where a sugar free product is available.

4. For young children requiring doses of less than 5ml an oral syringe will be dispensed.

 

Suspected Meningitis

Pre-admission management for suspected meningitis can be found here: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947389261

Notes: 

1. All GPs should carry benzylpenicillin for injection and administer it whilst arranging the transfer of the case to hospital, unless there is a history of immediate allergic reactions after previous penicillin administration.

2. GPs do not need to carry an alternative antibiotic. However, if other antibiotics are available, a 3rd generation cephalosporin may be used. If there is a history of immediate allergic reactions to penicillin or cephalosporins, chloramphenicol may be used.

3. Immediate dose of IV/IM benzylpenicillin for suspected meningococcal infection

  • Adults and children aged 10 years or over - 1.2g
  • Children aged 1 to 9 years - 600mg 
  • Children aged under 1 year - 300mg 
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (0,2)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (4,0)
05.01.01.02 Penicillinase-resistant penicillins (1,1)
05.01.01.03 Broad-spectrum penicillins (2,2)
05.01.01.04 Antipseudomonal penicillins (1,1)
05.01.01.05 Mecillinams (1,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactums (0,1)
Cephalosporins (1,5)
Other beta-lactam antibiotics (0,0)
05.01.02.01 Cephalosporins (6,7)
05.01.02.02 Carbapenems (3,0)
05.01.02.03 Other beta-lactums antibiotics (1,2)
05.01.03 Tetracyclines (5,2)
Tigecycline (1,0)
05.01.04 Aminoglycosides (4,7)
05.01.05 Macrolides (5,1)
05.01.06 Clindamycin (1,0)
05.01.07 Some other antibacterials (3,3)
Chloramphenicol (1,0)
Fosfomycin (1,0)
Fusidic acid (2,0)
Vancomycin and teicoplanin (3,1)
Daptomycin (1,0)
Linezolid (1,0)
Quinupristin and dalfopristin (0,1)
Polymyxins (1,2)
Rifaximin (1,0)
Fidaxomicin (1,0)
05.01.08 Sulphonamides and trimethoprim (3,1)
05.01.09 Antituberculosis drugs (9,8)
05.01.10 Antileprotic drugs (1,2)
05.01.11 Metronidazole and tinidazole (2,1)
05.01.12 Quinolones (4,3)
05.01.13 Urinary-tract infections (3,0)
05.02 Antifungal drugs (6,7)
Treatment of fungal infections (0,0)
Drugs used in fungal infections (0,0)
05.02.01 Triazole antifungals (0,0)
05.02.02 Imidazole antifungals (0,0)
05.02.03 Polyene antifungals (0,0)
05.02.04 Echinocandin antifungals (2,1)
05.02.05 Other antifungals (0,0)
05.03 Antiviral drugs (0,1)
05.03.01 HIV infection (3,4)
Nucleoside reverse transcriptase inhibitors (16,1)
Protease inhibitors (6,5)
Non-nucleoside reverse transcriptase inhibitors (3,0)
Other antiretrovirals (5,0)
05.03.02 Herpesvirus infections (0,1)
05.03.02.01 Herpes simplex and varicella-zoster infection (3,1)
05.03.02.02 Cytomegalovirus infection (3,2)
05.03.03 Viral hepatitis (0,0)
05.03.03.01 Chronic hepatitis B (2,1)
05.03.03.02 Chronic hepatitis C (2,10)
05.03.04 Influenza (2,2)
05.03.05 Respiratory syncytial virus (1,1)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,1)
Treatment of malaria (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Prophylaxis against malaria (0,0)
Specific recommendations (0,0)
Artemether with lumefabtrine (1,0)
Chloroquine (1,0)
Mefloquine (0,1)
Primaquine (1,0)
Proguanil (0,3)
Pyrimethamine (2,1)
Quinine (1,0)
Tetracyclines (0,1)
05.04.02 Amoebicides (0,2)
05.04.03 Trichomonacides (0,1)
05.04.04 Antigiardial drugs (0,2)
05.04.05 Leishmaniacides (0,1)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (0,1)
05.04.08 Drugs for pneumocystis pneumonia (1,3)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (1,2)
05.05.02 Ascaricides (0,0)
05.05.03 Drugs for tapeworm infections (0,1)
Taenicides (0,0)
Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (0,1)
05.05.06 Filaricides (0,0)
05.05.07 Drugs for cutaneous larva migrans (0,1)
05.05.08 Drugs for strongyloidiasis (0,0)
netFormulary